Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1312-1314
Number of pages3
JournalJAMA - Journal of the American Medical Association
Volume307
Issue number12
DOIs
StatePublished - Mar 21 2012
Externally publishedYes

Fingerprint

Piperazines
Pyrimidines
Gastrointestinal Stromal Tumors
Gastrointestinal Neoplasms
Antineoplastic Agents
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{7f418c041e124cf4ac819be25da77fce,
title = "Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors",
author = "Charles Blanke",
year = "2012",
month = "3",
day = "21",
doi = "10.1001/jama.2012.368",
language = "English (US)",
volume = "307",
pages = "1312--1314",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumors

AU - Blanke, Charles

PY - 2012/3/21

Y1 - 2012/3/21

UR - http://www.scopus.com/inward/record.url?scp=84859186912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859186912&partnerID=8YFLogxK

U2 - 10.1001/jama.2012.368

DO - 10.1001/jama.2012.368

M3 - Article

C2 - 22453573

AN - SCOPUS:84859186912

VL - 307

SP - 1312

EP - 1314

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 12

ER -